Relentless Progress to End the Pandemic
Philanthropy makes it possible for science to move at the speed of the pandemic. With support from generous donors, Fred Hutch researchers have been at the center of an unprecedented scientific sprint to stop the coronavirus — and now we are entering a new phase.
The vaccine rollouts that bring fresh hope come against a heartbreaking backdrop: COVID-19 is out of control in the U.S., with nearly 200,000 new infections every day. Hospitals are stretched to capacity, and every minute the virus takes another life.
COVID-19 is far from over — and neither is its impact on our communities, our nation, and the world. Our scientists need your support to maintain momentum as we navigate the pandemic’s most dangerous phase.
- We leveraged our decades of experience developing HIV vaccines to design, coordinate, and co-lead massive, successful vaccine trials for the federal government’s COVID-19 Prevention Network (CoVPN). Now we need your support for the next phase of work, including learning how vaccines affect long-term immunity, evaluating vaccines in children, expanding uptake, and more.
- Since opening the nation's first freestanding COVID-19 clinical research center in October, we've become the partner of choice for major studies of experimental treatments for early-stage coronavirus infection. With your support, we will expand the number and type of studies we conduct — and give health care providers more and better treatments to offer their patients.
These bold initiatives are funded, in part, by government and industry — but philanthropic support plays a unique role in accelerating progress. Donors have contributed $9 million to date to our COVID-19 Research Fund, fueling innovation across our campus. We are currently seeking an additional $2 million in private funding to sustain the clinical research center, support lab-based research, and nurture our scientists’ most fearless ideas.
Why Does Fred Hutch Study Viruses?
Our pioneering work in bone marrow transplantation revealed the urgent need to protect transplant patients from deadly infections, which launched our quest to gain an in-depth understanding of the immune system.
Today, we’re known for our expertise in virology and infectious disease. We are working in the laboratory, the clinic, and the cloud to find better ways to detect, prevent, and treat viruses and other infections to protect patients and communities. Working across disciplines, we are studying how HIV and other viruses evolve, learning how pathogens cause cancers, and developing and advancing treatments that harness patients’ own immune systems to fight disease.
We track epidemics to guide public health officials’ strategies to contain outbreaks of diseases like Zika, Ebola, and now COVID-19. As home to the HIV Vaccine Trials Network — the world’s largest international collaboration to develop vaccines that protect against the virus — we were able to quickly mobilize to design, coordinate, and co-lead massive COVID-19 federal vaccine trials as part of the COVID-19 Prevention Network.
Your gift to our COVID-19 Research Fund allows us to leverage decades of expertise and infrastructure to end this pandemic and prepare for the next health threat.
Please give today.